Atlas Trials

Maintenance Therapy of Chidamide in Patients With HBV Positive Diffuse Large B-cell Lymphoma

Clinical trial NCT04661943 · COMPLETED

Trial details

NCT number
NCT04661943
Sponsor
Ou Bai, MD/PHD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-cell Lymphoma
Start date
2017-06-01
Primary completion
2024-07-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.